Cellectis SA (XPAR:ALCLS)
€ 1.48 -0.02 (-1.33%) Market Cap: 148.14 Mil Enterprise Value: -14.65 Mil PE Ratio: 0 PB Ratio: 1.29 GF Score: 44/100

Q1 2024 Cellectis SA Earnings Call Transcript

May 29, 2024 / 12:00PM GMT
Release Date Price: €2.4 (-2.24%)
Operator

Good morning, everyone, and welcome to the Cellectis first-quarter 2024 earnings call. (Operator Instructions) Please be aware that today's conference call is being recorded.

I'd now like to turn the conference over to your first speaker Arthur Stril, Interim Chief Financial Officer. You may begin.

Arthur Stril
Cellectis SA - Interim Chief Financial Officer

Good morning, and welcome, everyone, to Cellectis first quarter 2024 corporate update and financial results conference call. Joining me on the call today are Dr. André Choulika, our Chief Executive Officer, and Dr. Mark Frattini, our Chief Medical Officer.

Yesterday evening, Cellectis issued a 6-K and a press release reporting our financial statements for the three month period ending March 31, 2024, and a corporate and business update. The report and press release are available on our website at cellectis.com.

As a reminder, we will make statements regarding Cellectis financial outlook, including the sufficiency of cash to fund operations in addition to its manufacturing,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot